ALPS Advisors’s Icosavax, Inc. Common Stock ICVX Stock Holding History

ALPS Advisors’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-35,434	Closed	-$558K	–	1089
2023 Q4	$558K	Buy	+35,434	New	+$341K	﹤0.01%	589
2022 Q4	–	Sell	-21,821	Closed	-$69K	–	1098
2022 Q3	$69K	Sell	21,821 -1,744	-7%	-$10.9K	﹤0.01%	1035
2022 Q2	$135K	Buy	+23,565	New	+$184K	﹤0.01%	1016

ALPS Advisors's ICVX Position: Q1 2024 in Review

ALPS Advisors sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 35,434 shares — an estimated $558K sold.

ALPS Advisors first reported a position in ICVX in Q2 2022 and held it in 3 quarters. The position peaked at $558K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

ALPS Advisors reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
ALPS Advisors sold 35,434 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $558K.
ALPS Advisors first reported a position in Icosavax, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
ALPS Advisors's Icosavax, Inc. Common Stock position peaked at $558K in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on ALPS Advisors's 13F filing for Q1 2024, filed 14 May 2024.